投融资数据库
免费查数据
注册送3天会员
首页>投融资
Sparrow Pharmaceuticals
B轮
Sparrow Pharmaceuticals Inc is a virtual-drug development company focused on the acquisition of de-prioritized mid-stage drug candidates with strong clinical potential and global patent protection. The company conduct phase 2 trials to establish proof-of-concept, identify clinically meaningful differentiation from existing treatments and formulation/doses for future clinical trials, and further identifies partner to complete the drug development.In May 2021, Sparrow Pharmaceuticals Inc closed a $50 million Series A financing
基本信息
-
公司全称Sparrow Pharmaceuticals Inc
-
类型临床阶段生物制药商
-
产业领域医药研发/制造、化学&生物药
-
公司人数15人以下
-
地址920 SW 6TH AVE SUITE 1200 PORTLAND OREGON 97204; US; Telephone: +13127528446;
-
联系电话617-465-0328
-
邮箱info@sparrowpharma.com
-
成立时间2013-01-01
投融资
-
2025-09-24
-
2021-05-18
相关投融资企业
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
收并购
Kronos Bio, Inc.于2017年6月2日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新的癌症疗法，旨在通过针对失调转录的精确药物策略来改变患者的预后。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息